SEC-sourced researchBeta
MRNA
Moderna, Inc.
Company comparison ↗
Data passport
- CIK
- 0001682852
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Oct 7, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 6,848,000,000.0000 | Feb 20, 2026 |
| December 2024 | 3,236,000,000.0000 | Feb 20, 2026 |
| December 2025 | 1,944,000,000.0000 | Feb 20, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,944,000,000.0000 | -2,822,000,000.0000 | -1,873,000,000.0000 | 12,338,000,000.0000 | 3,688,000,000.0000 | Feb 20, 2026 |
| December 2024 | 3,236,000,000.0000 | -3,561,000,000.0000 | -3,004,000,000.0000 | 14,142,000,000.0000 | 3,241,000,000.0000 | Feb 20, 2026 |
| December 2023 | 6,848,000,000.0000 | -4,714,000,000.0000 | -3,118,000,000.0000 | — | — | Feb 20, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.94B | December 2025 | Feb 20, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $3.24B | December 2024 | Feb 20, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$2.82B | December 2025 | Feb 20, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$1.87B | December 2025 | Feb 20, 2026 | 10-K |
| Total assetsAssets | $12.34B | December 2025 | Feb 20, 2026 | 10-K |
| Total liabilitiesLiabilities | $3.69B | December 2025 | Feb 20, 2026 | 10-K |
New filings
- 4MRNA · Moderna, Inc.Oct 7, 2026 · Other
- 3MRNA · Moderna, Inc.Oct 5, 2026 · Other
- 8-KMRNA · Moderna, Inc.Sep 30, 2026 · Current event
- 4MRNA · Moderna, Inc.Sep 16, 2026 · Other
- 144MRNA · Moderna, Inc.Sep 15, 2026 · Other
- 144MRNA · Moderna, Inc.Sep 14, 2026 · Other
- 4MRNA · Moderna, Inc.Sep 14, 2026 · Other
- 144MRNA · Moderna, Inc.Sep 10, 2026 · Other
- 4MRNA · Moderna, Inc.Sep 8, 2026 · Other
- 4MRNA · Moderna, Inc.Sep 8, 2026 · Other
- 4MRNA · Moderna, Inc.Sep 3, 2026 · Other
- 4MRNA · Moderna, Inc.Sep 3, 2026 · Other
- 4MRNA · Moderna, Inc.Sep 3, 2026 · Other
- 144MRNA · Moderna, Inc.Sep 1, 2026 · Other
- 8-KMRNA · Moderna, Inc.Sep 1, 2026 · Current event
- 4MRNA · Moderna, Inc.Aug 31, 2026 · Other
- 4MRNA · Moderna, Inc.Aug 31, 2026 · Other
- 4MRNA · Moderna, Inc.Aug 31, 2026 · Other
- 10-KMRNA · MODERNA, INC.Feb 20, 2026 · Annual